Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

Published by GlobalData Product code 974396
Published Content info 86 Pages
Delivery time: 1-2 business days
Price
Back to Top
Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020
Published: November 30, 2020 Content info: 86 Pages
Description

GlobalData's Medical Devices sector report, "Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Viruses Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hepatitis Viruses Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Hepatitis B and C.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hepatitis Viruses Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME1035EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Hepatitis Viruses Rapid Tests & POC Overview

3 Products under Development

  • 3.1 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
  • 3.2 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
  • 3.3 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
  • 3.4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date

4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products under Development by Companies

  • 4.1 Hepatitis Viruses Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • 4.2 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development

5 Hepatitis Viruses Rapid Tests & POC Companies and Product Overview

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
  • Table 2: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
  • Table 3: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Table 4: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date
  • Table 5: Hepatitis Viruses Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • Table 6: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
  • Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Status
  • Table 9: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Description
  • Table 10: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: PIFA Hep B / Hep C - Product Status
  • Table 12: PIFA Hep B / Hep C - Product Description
  • Table 13: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Alere q Analyzer - HCV VL Assay - Product Status
  • Table 15: Alere q Analyzer - HCV VL Assay - Product Description
  • Table 16: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Rapid Immunoassay - HCV - Product Status
  • Table 18: Rapid Immunoassay - HCV - Product Description
  • Table 19: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: AtomoRapid - Hepatitis C - Product Status
  • Table 21: AtomoRapid - Hepatitis C - Product Description
  • Table 22: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Idylla Viral Load Assay - HBV - Product Status
  • Table 24: Idylla Viral Load Assay - HBV - Product Description
  • Table 25: Idylla Viral Load Assay - HCV - Product Status
  • Table 26: Idylla Viral Load Assay - HCV - Product Description
  • Table 27: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: INSTI Test - Hepatitis C - Product Status
  • Table 29: INSTI Test - Hepatitis C - Product Description
  • Table 30: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Spinit Device - Hepatitis C Biomarker Assay - Product Status
  • Table 32: Spinit Device - Hepatitis C Biomarker Assay - Product Description
  • Table 33: Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Diagnostic Kit - Hepatitis A - Product Status
  • Table 35: Diagnostic Kit - Hepatitis A - Product Description
  • Table 36: Biotech Resources Aust Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: ATR-FTIR System - Hepatitis B & C - Product Status
  • Table 38: ATR-FTIR System - Hepatitis B & C - Product Description
  • Table 39: Blink AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Status
  • Table 41: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Description
  • Table 42: Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Paper Based Test - HBV - Product Status
  • Table 44: Paper Based Test - HBV - Product Description
  • Table 45: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: GeneXpert Omni - HCV Viral Load - Product Status
  • Table 47: GeneXpert Omni - HCV Viral Load - Product Description
  • Table 48: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: DPP Hepatitis C Virus Assay - Product Status
  • Table 50: DPP Hepatitis C Virus Assay - Product Description
  • Table 51: Next Generation DPP HCV Assay - Product Status
  • Table 52: Next Generation DPP HCV Assay - Product Description
  • Table 53: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Diagnostic Assay - Hepatitis C - Product Status

List of Figures

List of Figures

  • Figure 1: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
  • Figure 2: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
  • Figure 3: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Figure 4: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Back to Top